APA (7th ed.) Citation

MO, F., LC, P., RE, R., L, S., V, H., G, M., . . . HM, P. (2026). A Slc5a6-deficient mouse model reveals metabolically driven cardiomyopathy with therapeutic potential for vitamin-based intervention. JCI insight, 11(14), . https://doi.org/10.1172/jci.insight.200381

Chicago Style (17th ed.) Citation

MO, Fullerton, et al. "A Slc5a6-deficient Mouse Model Reveals Metabolically Driven Cardiomyopathy with Therapeutic Potential for Vitamin-based Intervention." JCI Insight 11, no. 14 (2026). https://doi.org/10.1172/jci.insight.200381.

MLA (9th ed.) Citation

MO, Fullerton, et al. "A Slc5a6-deficient Mouse Model Reveals Metabolically Driven Cardiomyopathy with Therapeutic Potential for Vitamin-based Intervention." JCI Insight, vol. 11, no. 14, 2026, https://doi.org/10.1172/jci.insight.200381.